Cancer strategies among themes of Canada-Australia healthcare co-op:
This article was originally published in Clinica
Executive Summary
Canada and Australia signed a four-year agreement on healthcare co-operation at the Asian Pacific Economic Cooperation (APEC) health ministers' meeting in Sydney on June 6. Access to healthcare, cancer strategies, and exchange of best practices and knowledge are among the key areas covered by the Canada-Australia health policy dialogue. The agreement, which extends to December 31 2011, is also expected to promote co-operation between research institutions and health associations.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.